PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-05-17

Date Title Company
17-May-2022 Surgical Broaches Market Industry Trends, Share, Size and Analysis Report to 2028 MARKITWIRED
17-May-2022 Acetaminophen Api Market Industry Trends, Share, Size and Analysis Report to 2030 MARKITWIRED
17-May-2022 Nutrition Therapy Market Industry Trends, Share, Size and Analysis Report to 2028 MARKITWIRED
17-May-2022 Pharmaceutical Caps and Closures Market Expecting a 5.7 % CAGR between 2021 -2031 MARKITWIRED
17-May-2022 Laryngoscopes Market Projected to Rise at a CAGR of over 5.0 % between 2020 and 2030 MARKITWIRED
17-May-2022 Dual and Multi-Energy Computed Tomography (CT) Market Projecting at a High CAGR of 8.2% by The End of 2029 MARKITWIRED
17-May-2022 Corneal Ulcer Treatment Market is Expected to Experience a Significant Growth of 5.7% CAGR 2022 – 2029 MARKITWIRED
17-May-2022 Clinical Oncology Next-generation Sequencing Market Reaching a Total Valuation of US$ 1.14 Billion by 2029 MARKITWIRED
17-May-2022 Bioimpedance Devices Market is Projected to Reach Total Valuation of US$ 715.1 Million by 2028 MARKITWIRED
17-May-2022 Prefilled Formalin Vials Market is Expected to Reach Total Valuation of US$ 515.8 Million by The End of 2028 MARKITWIRED
17-May-2022 Cardiac Biomarker Diagnostic Test Kits Market is Projected to Expand at 5.1% CAGR Over The Forecast Period, From 2022 to 2028 MARKITWIRED
17-May-2022 Dry Powder Inhaler Market is set to experience a significant growth of 4.6% CAGR from 2021 to 2031 MARKITWIRED
17-May-2022 Anti-microbial/Anti-fungal Tests Market is Projected to witness Higher CAGR of 5.6% 2017 -2027 MARKITWIRED
17-May-2022 N4 Pharma highlights potential of Nuvec® as gene therapy delivery platform N4 Pharma
17-May-2022 IMFINZI (durvalumab) ACCEPTED FOR ROUTINE USE WITHIN NHS ENGLAND FOR ADULTS WITH STAGE III UNRESECTABLE NON-SMALL CELL LUNG CANCER AstraZeneca
17-May-2022 United Kingdom Medicines and Healthcare Products Regulatory Agency (MHRA) grants Marketing Authorization for FYB201, Formycon's Biosimilar for Lucentis®1 to be Commercialized by Teva as ONGAVIA® Formycon AG
17-May-2022 Eagle Genomics’ Anthony Finbow to Discuss Microbiome Science’s Role in Transforming Food and Nutrition at Food 4 Future in Bilbao Eagle Genomics
17-May-2022 FYB201, Formycon's Biosimilar for Lucentis®1 achieves Marketing Authorization in United Kingdom Formycon AG
17-May-2022 BeiGene Strengthens European Presence with the Opening of Regional Office in Basel, Switzerland BeiGene
17-May-2022 Study launched to investigate Covid-19 vaccine protection in young, immunosuppressed people Kidney Research UK